Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
Open accessThe DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Abstract
Psilocybin shows efficacy to alleviate depression in human clinical trials for six or more months after only one or two treatments. Another hallucinogenic drug, esketamine, has recently been U.S. Food and Drug Administration (FDA)-approved as a rapid-acting antidepressant. The mechanistic basis for the antidepressant effects of psilocybin and ketamine appear to be conserved. The efficacy of these two medications has not, however, been directly compared either clinically or preclinically. Further, whether or not a profound subjective existential experience is necessary for psilocybin to have antidepressant effects is unknown. To address these questions, we tested psilocybin, lysergic acid diethylamide (LSD), and ketamine in a rat model for depression. As in humans, a single administration of psilocybin or LSD produced persistent antidepressant-like effects in our model. In contrast, ketamine produced only a transient antidepressant-like effect. Our results indicate that classic psychedelics may have therapeutic efficacy that is more persistent than that of ketamine, and also suggest that a subjective existential experience may not be necessary for therapeutic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ketamine's effects on structural plasticity appear to last for approximately a week (150) while psilocybin's effects seem to be more durable lasting for at least a month (151, 152)”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [151]
In the citing paper
“This may explain why they have demonstrated efficacy in many preclinical rodent behavioral tests involving PFC circuitry including the forced swim test and fear extinction learning (151, 194–197).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [151]
In the citing paper
“the mood-elevating properties of psilocybin seem to last significantly longer”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [151]
Citations
Cites
A Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Depression: a new animal model sensitive to antidepressant treatments
PORSOLT, R. D., LE PICHON, M., & JALFRE, M. (1977) · Nature · doi:10.1038/266730a0 · Cited by 4,451
The use of the elevated plus maze as an assay of anxiety-related behavior in rodents
Walf, A. A., & Frye, C. A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.44 · Cited by 3,035
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Using the rat forced swim test to assess antidepressant-like activity in rodents
Slattery, D. A., & Cryan, J. F. (2012) · Nature Protocols · doi:10.1038/nprot.2012.044 · Cited by 903
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808
Murrough, J. W., Perez, A. M., Pillemer, S., Stern, J., Parides, M. K., aan het Rot, M., Collins, K. A., Mathew, S. J., Charney, D. S., & Iosifescu, D. V. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.022 · Cited by 786
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, C., & Kunugi, H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.018 · Cited by 673
Rat brains also have a default mode network
Lu, H., Zou, Q., Gu, H., Raichle, M. E., Stein, E. A., & Yang, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200506109 · Cited by 603
Sex differences in animal models of psychiatric disorders
Kokras, N., & Dalla, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12710 · Cited by 425
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: A Review
Sinyor, M., Schaffer, A., & Levitt, A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500303 · Cited by 396
The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder
Jernigan, C. S., Goswami, D. B., Austin, M. C., Iyo, A. H., Chandran, A., Stockmeier, C. A., & Karolewicz, B. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.05.010 · Cited by 386
Psychedelics as Medicines: An Emerging New Paradigm
Nichols, D., Johnson, M., & Nichols, C. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.557 · Cited by 370
Self-citationStrain Differences in the Behavioral Effects of Antidepressant Drugs in the Rat Forced Swimming Test
López-Rubalcava, C. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00100-1 · Cited by 345
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. (2019) · Nature · doi:10.1038/s41586-019-1075-9 · Cited by 334
McLaughlin, K. J., Gomez, J. L., Baran, S. E., & Conrad, C. D. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.042 · Cited by 314
Brenes Sáenz, J. C., Villagra, O. R., & Fornaguera Trías, J. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.12.001 · Cited by 290
Lam, R. W., Levitt, A. J., Levitan, R. D., Michalak, E. E., Cheung, A. H., Morehouse, R., Ramasubbu, R., Yatham, L. N., & Tam, E. M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2235 · Cited by 275
Sex Differences in Animal Models of Depression and Antidepressant Response
Dalla, C., Pitychoutis, P. M., Kokras, N., & Papadopoulou‐Daifoti, Z. (2010) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00516.x · Cited by 238
Modeling Depression in Animal Models
Overstreet, D. H. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-458-2_7 · Cited by 231
Maeng, S., & Zarate, C. A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0063-1 · Cited by 229
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220
Amplified behavioral and endocrine responses to forced swim stress in the Wistar–Kyoto rat
Rittenhouse, P. A., López-Rubalcava, C., Stanwood, G. D., & Lucki, I. (2002) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(01)00052-x · Cited by 207
The role of mTOR in depression and antidepressant responses
Abelaira, H. M., Réus, G. Z., Neotti, M. V., & Quevedo, J. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.014 · Cited by 186
The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs
Gałecki, P., Mossakowska-Wójcik, J., & Talarowska, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.016 · Cited by 180
Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy
Hendricks, P. S. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1474185 · Cited by 179
Tizabi, Y., Bhatti, B. H., Manaye, K. F., Das, J. R., & Akinfiresoye, L. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.052 · Cited by 173
Effects of N,N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00134 · Cited by 171
Garza, R. D. L., & Mahoney, J. J. (2004) · Brain Research · doi:10.1016/j.brainres.2004.06.052 · Cited by 144
Are Wistar-Kyoto rats a genetic animal model of depression resistant to antidepressants?
Lahmame, A., del Arco, C., Pazos, Á., Yritia, M., & Armario, A. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01276-4 · Cited by 144
Solberg, L. C., Olson, S. L., Turek, F. W., & Redei, E. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.281.3.r786 · Cited by 141
Sarkar, A., & Kabbaj, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.025 · Cited by 134
Ampuero, E., Rubio, F. J., Falcon, R., Sandoval, M., Diaz-Veliz, G., Gonzalez, R. E., Earle, N., Dagnino-Subiabre, A., Aboitiz, F., Orrego, F., et al. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.035 · Cited by 132
Hurley, L. L., Akinfiresoye, L., Nwulia, E., Kamiya, A., Kulkarni, A. A., & Tizabi, Y. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.049 · Cited by 127
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
Carr, G. V., Bangasser, D. A., Bethea, T., Young, M., Valentino, R. J., & Lucki, I. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.183 · Cited by 124
Reiche, S., Hermle, L., Gutwinski, S., Jungaberle, H., Gasser, P., & Majić, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.012 · Cited by 122
Sex differences and stress response of WKY rats
Paré, W. P., & Redei, E. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90345-g · Cited by 117
Dong, C., Zhang, J.-C., Yao, W., Ren, Q., Ma, M., Yang, C., Chaki, S., & Hashimoto, K. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw089 · Cited by 116
Rong, C., Park, C., Rosenblat, J. D., Subramaniapillai, M., Zuckerman, H., Fus, D., Lee, Y. L., Pan, Z., Brietzke, E., Mansur, R. B., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15040771 · Cited by 114
Mezadri, T., Batista, G. M., Portes, A. C., Marino–Neto, J., & Lino-de-Oliveira, C. (2010) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2010.12.015 · Cited by 110
Österlund, M. K., Overstreet, D. H., & Hurd, Y. L. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00274-0 · Cited by 97
McAuley, J. D., Stewart, A. L., Webber, E. S., Cromwell, H. C., Servatius, R. J., & Pang, K. C. H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.036 · Cited by 90
Structure–activity relationships of serotonin 5‐HT2Aagonists
Nichols, D. E. (2012) · Wiley Interdisciplinary Reviews: Membrane Transport and Signaling · doi:10.1002/wmts.42 · Cited by 81
Effect of stress on the behavior and 5-HT system in Sprague-Dawley and Wistar Kyoto rat strains
Paré, W. P., & Tejani‐Butt, S. M. (1996) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02699783 · Cited by 73
Buchborn, T., Schröder, H., Höllt, V., & Grecksch, G. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114531666 · Cited by 72
Psilocybin lacks antidepressant-like effect in the Flinders Sensitive Line rat
Jefsen, O., Højgaard, K., Christiansen, S. L., Elfving, B., Nutt, D. J., Wegener, G., & Müller, H. K. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.15 · Cited by 63
Páleníček, T., Hlinak, Z., Bubeníková‐Valešová, V., Novák, T., & Horáček, J. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.02.008 · Cited by 62
du Jardin, K. G., Liebenberg, N., Cajina, M., Müller, H. K., Elfving, B., Sanchez, C., & Wegener, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00978 · Cited by 47
Yamada, M., Kawahara, Y., Kaneko, F., Kishikawa, Y., Sotogaku, N., Poppinga, W. J., Folgering, J. H. A., Dremencov, E., Kawahara, H., & Nishi, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.044 · Cited by 37
Turner, R. C., Seminerio, M. J., Naser, Z. J., Ford, J. N., Martin, S. J., Matsumoto, R. R., Rosen, C. L., & Huber, J. D. (2012) · Journal of neurosurgery · doi:10.3171/2012.5.jns112224 · Cited by 34
Maintenance Ketamine Therapy for Treatment-Resistant Depression
Archer, S., Chrenek, C., & Swainson, J. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000894 · Cited by 34
Psilocybin: Biphasic dose-response effects on the acoustic startle reflex in the rat
Davis, M., & Walters, J. K. (1977) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(77)90180-0 · Cited by 29
Antidepressant Augmentation With Anti-Inflammatory Agents
Andrade, C. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14f09432 · Cited by 28
Li, Q., Hosaka, T., Harada, N., Nakaya, Y., & Funaki, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.022 · Cited by 25
Visual recognition of mirror, video-recorded, and still images in rats
Yakura, T., Yokota, H., Ohmichi, Y., Ohmichi, M., Nakano, T., & Naito, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194215 · Cited by 23
Du Jardin, K. G., Müller, H. K., Sanchez, C., Wegener, G., & Elfving, B. (2017) · Synapse · doi:10.1002/syn.21940 · Cited by 20
Hibicke, M., Graham, M. A., & Hayslett, R. L. (2017) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000119 · Cited by 13
Self-citationKandi, P., Hibicke, M., & Hayslett, R. L. (2015) · Journal of Pharmaceutical Sciences and Pharmacology · doi:10.1166/jpsp.2015.1064 · Cited by 3
Self-citation
Research works printed but not linked: 3
- Russell, 2009, The three Rs and the humanity criterion
- Hibicke, M. (2017) Development and Evaluation of an Adolescent Chronic Restraint Stress (ACRS) Protocol to Model Adult Depression in Female Rats. Ph.D. Thesis, Mercer University.
- Sengupta, 2013, The Laboratory Rat: Relating Its Age With Human’s, Int. J. Prev. Med., 4, 624
Cited by
The subjective effects of psychedelics are necessary for their enduring therapeutic effects
Yaden, D. B., & Griffiths, R. R. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00194 · Cited by 541
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB
Moliner, R., Girych, M., Brunello, C. A., Kovaleva, V., Biojone, C., Enkavi, G., Antenucci, L., Kot, E. F., Goncharuk, S. A., Kaurinkoski, K., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01316-5 · Cited by 478
Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022489118 · Cited by 378
“Although psilocybin has been reported to have delayed antidepressant-like effects in the forced swim test in some, but not all, strains of rats (13, 33), we were unable to replicate this finding in mice.”
BackgroundMethodInfluentialThe neural basis of psychedelic action
Kwan, A. C., Olson, D. E., Preller, K. H., & Roth, B. L. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01177-4 · Cited by 302
Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics
Aleksandrova, L. R., & Phillips, A. G. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.003 · Cited by 276
Metadata
- Authors
- Hibicke, M., Landry, A. N., Kramer, H. M., Talman, Z. K., & Nichols, C. D.
- Affiliations
- Louisiana State University (US)
- Corresponding author
- Nichols, Charles D.
- Venue
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-03-05
- Volume
- 11
- Issue
- 6
- Pages
- 864-871
- ISSN
- 1948-7193 (ISSN-L)
- OpenAlex
- W3010499243
- Cited by
- 205
- References
- 65
- Citations by year
- 2026: 20 · 2025: 34 · 2024: 38 · 2023: 40 · 2022: 42 · 2021: 20 · 2020: 11
- FWCI
- 11.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- ACS Chemical Neuroscience (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- Eleusis PBC (NA)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- psilocybin, LSD, ketamine, psychedelics, antidepressant effects, depression, subjective experience, rat model of depression, rapid-acting antidepressants
- MeSH terms
- Animals, Antidepressive Agents, Depression, Hallucinogens, Ketamine, Rodentia, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.